PTEN and cancer: Studies have suggested that mTORC1/C2 inhibitors have more effect on PTEN-mutated cancers.46, 47 Our results convincingly showed the mechanism whereby PTEN mutations increase the sensitivity of cancers to mTORC1/2 inhibitors.